Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
PaperCitations, authors & open-access status
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 133 citations, 2015 year and bronze oa status.
133
Citations
2015
Year
bronze
OA Status